Emergent Biosolutions EBS MCM Products — Total depreciation

Other segment segments

Similar metrics at other companies

ENTGMS — Total depreciation

$14.2M-36.6%

BCCorporate Segment — Depreciation

$1.3M+8.3%

CSL

CSLCCM — D&A

$22.8M+5.6%

OIIManufactured Products Member — Depreciation, Depletion and Amortization

$2.77M+4.7%

NGVTPerformance Materials — Total depreciation and amortization

$10.9M+10.1%

TRSCorporate Segment — Depreciation, Depletion and Amortization

$110K+37.5%

Questions, answered.

What is Emergent Biosolutions's MCM products — total depreciation?

Emergent Biosolutions (EBS) reported MCM products — total depreciation of $4.6M in Q1 2026.

How has Emergent Biosolutions's MCM products — total depreciation changed year-over-year?

Emergent Biosolutions's MCM products — total depreciation increased by 9.5% year-over-year, from $4.2M to $4.6M.

What is the long-term trend for Emergent Biosolutions's MCM products — total depreciation?

Over 4 years (2021 to 2025), Emergent Biosolutions's MCM products — total depreciation has grown at a -7.5% compound annual growth rate (CAGR), from $24.7M to $18.1M.

What does MCM products — total depreciation mean?

This reflects the systematic allocation of the cost of tangible assets used by the MCM segment over their useful lives. It is a key non-cash expense that impacts the segment's reported profitability and reflects the intensity of capital asset utilization.